phenylephrine + tempol

Phenylephrine + tempol is a combination drug consisting of phenylephrine, an alpha-1 adrenergic receptor agonist primarily used as a decongestant and vasopressor, and tempol, a nitroxide antioxidant with superoxide dismutase-mimetic activity. Phenylephrine acts by stimulating alpha-1 adrenergic receptors to induce vasoconstriction, leading to reduced nasal congestion or increased blood pressure depending on the route of administration[1][2]. Tempol is known for its ability to scavenge reactive oxygen species and reduce oxidative stress; it has been investigated in preclinical studies for potential cardiovascular and neuroprotective effects. The combination may be explored for synergistic effects in conditions where both vasoconstriction (from phenylephrine) and reduction of oxidative stress (from tempol) are desired. However, there is no evidence from the provided sources that this specific combination is approved or marketed.